Author

Ildem Sanli

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alison M. MeynertiD· 1 shared Andrew J. WoodiD· 1 shared Gillian C.A. TayloriD· 1 shared Kallimasioti Pazi· 1 shared Keerthi T. Chathoth· 1 shared Martijn J. E. Kelder· 1 shared Robert FeiliD· 1 shared Sébastien Lalevée· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Alison M. MeynertORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Heterochromatin delays CRISPR-Cas9 mutagenesis but does not influence repair outcome

Kallimasioti Pazi, Keerthi T. Chathoth, Gillian C.A. Taylor, Alison M. Meynert, Tracy J. Ballinger, Martijn J. E. Kelder, Sébastien Lalevée, Ildem Sanli, Robert Feil, Andrew J. Wood

The paper shows heterochromatin slows CRISPR-Cas9 mutagenesis but does not affect repair outcomes, with mutagenesis inhibition depending on Cas9 exposure levels.

PLoS Biology · Dec 12, 2018Peer-reviewedGenetics